We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

$1.4B Zyprexa Deal Could Spark More Qui Tam Suits

Law360 (January 15, 2009, 12:00 AM EST) -- Eli Lilly & Co.'s record-breaking $1.4 billion deal to settle charges that it illegally marketed its anti-psychotic treatment Zyprexa for off-label use could stimulate, one observer says, a wave of false as well as legitimate whistleblower complaints.

The Indiana-based pharmaceutical giant's agreement with the U.S. Attorney's Office for the Eastern District of Pennsylvania and 30 states, announced Thursday, is believed to be the largest-ever health care fraud settlement and resolves four qui tam cases that were consolidated in the U.S. District Court for the Eastern District...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.